VERGELLI, CLAUDIA
 Distribuzione geografica
Continente #
EU - Europa 2.980
NA - Nord America 2.850
AS - Asia 298
AF - Africa 6
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.140
Nazione #
US - Stati Uniti d'America 2.845
PL - Polonia 1.867
IT - Italia 264
SE - Svezia 241
IE - Irlanda 240
HK - Hong Kong 131
GB - Regno Unito 84
UA - Ucraina 77
DE - Germania 70
CN - Cina 68
FI - Finlandia 48
VN - Vietnam 35
RU - Federazione Russa 26
JO - Giordania 25
BE - Belgio 23
SG - Singapore 22
ES - Italia 13
FR - Francia 12
TR - Turchia 12
NL - Olanda 7
BR - Brasile 5
CA - Canada 5
IN - India 4
SC - Seychelles 4
CH - Svizzera 3
RO - Romania 3
EG - Egitto 2
BY - Bielorussia 1
CZ - Repubblica Ceca 1
EU - Europa 1
JP - Giappone 1
Totale 6.140
Città #
Warsaw 1.866
Fairfield 445
Chandler 289
Dublin 239
Seattle 218
Ashburn 216
Cambridge 178
Woodbridge 177
Houston 153
Ann Arbor 144
Wilmington 134
Jacksonville 128
Florence 102
Altamura 88
Lawrence 83
Hong Kong 81
Princeton 71
Buffalo 56
Boardman 40
Boston 37
Medford 37
Beijing 32
Dong Ket 27
San Diego 26
Shanghai 24
Brussels 22
London 18
New York 18
Moscow 17
Singapore 15
Barcelona 13
Hillsboro 12
Norwalk 10
West Jordan 10
Izmir 9
Phoenix 9
Falls Church 7
Frankfurt Am Main 7
Kent 7
Los Angeles 7
Milan 7
Fuzhou 5
Gavirate 5
Teresópolis 5
Andover 4
Napoli 4
Philadelphia 4
Tappahannock 4
Toronto 4
Auburn Hills 3
Bern 3
Esslingen am Neckar 3
Menlo Park 3
Misano Adriatico 3
Pune 3
Scandicci 3
Verona 3
Zhengzhou 3
Amsterdam 2
Carol Stream 2
Castelliri 2
Crawley 2
Dearborn 2
Lappeenranta 2
Leawood 2
Paris 2
Prescot 2
Redwood City 2
Salerno 2
Southwark 2
Timisoara 2
Trumbull 2
Whitechapel 2
Antwerpen 1
Atlanta 1
Bologna 1
Cairo 1
Campi Bisenzio 1
Chicago 1
Chieti 1
Dallas 1
Ergolding 1
Foligno 1
Garden City 1
Guangzhou 1
Hanover 1
Helsinki 1
Hounslow 1
Istanbul 1
Laurel 1
Minsk 1
Montecatini Terme 1
Montréal 1
North Babylon 1
Pescara 1
Redmond 1
Reggio Emilia 1
Rome 1
San Jose 1
San Pietro In Casale 1
Totale 5.198
Nome #
Synthesis, HPLC enantioresolution and X-ray analysis of a new series of C5-methyl pyridazines as N-formyl peptide receptor (FPR) agonists 240
[(3-chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents 230
Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists. 209
Synthesis and pharmacological evaluation of new pyridazin-based thioderivatives as formyl peptide receptor (FPR) agonists 207
Synthesis and evaluation as antitubercular agents of 5-arylethenyl and 5-(hetero)aryl-3-isoxazolecarboxylate 203
Synthesis and evaluation as PDE4 inhibitors of pyrimidine-2,4-dione derivatives 201
α2 Adrenoceptor: a Target for Neuropathic Pain Treatment 195
Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase 190
Synthesis, enantioresolution and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonists. 186
Isoxazolo-5(2H)-one: a new scaffold for potent human neutrophil elastase (HNE) inhibitors 177
New pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4-(3H)-ones fluoroderivatives as human A1 adenosine receptor ligands 169
Synthesis and pharmacological evaluation of novel GABAA subtype receptor ligands with potential anxiolytic-like and anti-hyperlagesic effect 167
Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase 162
2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists. 139
Synthesis of pyrrolo[2,3-d]pyridazinones as potent, subtype selective PDE4 inhibitors 126
Synthesis and pharmacological evaluation of indole derivatives as deaza analogues of potent human neutrophil elastase inhibitors 125
Synthesis of five and six-membered N-phenylacetamido substituted heterocycles as formyl peptide receptor agonists 124
Further studies on pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective human A1 adenosine receptor antagonists. 121
Synthesis and analytical characterization of new thiazol-2-(3H)-ones as human neutrophil elastase (HNE) inhibitors 115
Synthesis of New GABAA Receptor Modulator with Pyrazolo[1,5-a]quinazoline (PQ) Scaffold 109
Synthesis, biological evaluation, and molecular modelling studies of potent human neutrophil elastase (HNE) inhibitors 108
Cinnoline derivatives as human neutrophil elastase inhibitors 103
1H-pyrrolo[2,3-b]pyridine: a new scaffold for human neutrophil elastase (HNE) inhibitors 103
Effects of the neutrophil elastase inhibitor EL-17 in rat adjuvant-induced arthritis. 102
New pyrazolo[1',5':1,6]pyridazin-4(3H)-ones as potent and selective PDE5 inhibitors 98
Synthesis of five and six-membered heterocycles bearing an arylpiperazinylalkyl side chain as orally active antinociceptive agents 97
4-AMINO-3(2H)-PYRIDAZINONES BEARING ARYLPIPERAZINYLALKYL GROUPS AND RELATED COMPOUNDS: SYNTHESIS AND ANTINOCICEPTIVE ACTIVITY 95
Arylpiperazinylalkylpyridazinones and analogues as potent and orally active antinociceptive agents: synthesis and studies on mechanism of action 92
4-Amino-5-substituted-3(2H)-pyridazinones as orally active antinociceptive agents: synthesis and studies on the mechanism of action 90
SELECTIVE ACAT INHIBITORS AS PROMISING ANTIHYPERLIPIDEMIC, ANTIATHEROSCLEROTIC AND ANTI-ALZHEIMER DRUGS 88
ISOXAZOLO[3,4-D]PYRIDAZINONES AND ANALOGUES AS LEISHMANIA MEXICANA PDE INHIBITORS 88
Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: synthesis and evaluation of their phosphodiesterase 4 inhibitory activity 85
Further modifications of 1H-pyrrolo[2,3-b]pyridine derivatives as inhibitors of human neutrophil elastase 85
NOVEL 3-ARYLAMINO- AND 3-CYCLOALKYLAMINO-5,6-DIPHENYLPYRIDAZINES ACTIVE AS ACAT INHIBITORS 84
Identification of a new pyrazolo[1,5-a]quinazoline ligand highly affine to γ-aminobutyric type A (GABAA) receptor subtype with anxiolytic-like and antihyperalgesic activity 84
4-amino-5-vinyl-3(2H)-pyridazinones and analogues as potent antinociceptive agents: synthesis, SARs, and preliminary studies on the mechanism of action 83
6-Methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors. 77
AIRWAY RELAXANT AND ANTI-INFLAMMATORY PROPERTIES OF A PDE 4 INHIBITOR WITH LOW AFFINITY FOR THE HIGH-AFFINITY ROLIPRAM BINDING SITE 75
Further studies on arylpiperazinyl alkyl pyridazinones: discovery of an exceptionally potent, orally active, antinociceptive agent in thermally induced pain. 72
New 3-unsubstituted Isoxazolones as Potent Human Neutrophil Elastase Inhibitors: Synthesis and Molecular Dynamic Simulation 70
PDE5 Inhibitors and their applications 68
Pyrazolo[1,5-a]quinazoline scaffold as 5-deaza analogue of pyrazolo[5,1-c][1,2,4]benzotriazine system: synthesis of new derivatives, biological activity on GABAA receptor subtype and molecular dynamic study 64
1,5,6,7-Tetrahydro-4H-indazol-4-ones as human neutrophil elastase (HNE) inhibitors 64
New 3,6-disubstituted pyrazolo[1,5-a]quinazolines as ligands to GABAA receptor subtype 63
Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A1 adenosine receptor ligands 61
Exploration of Nitrogen Heterocycle Scaffolds for the Development of Potent Human Neutrophil Elastase Inhibitors 52
Novel pyrazolopyrimidopyridazinones with potent and selective phosphodiesterase 5 (PDE5) inhibitory activity agents as potential agents for treatment of erectile dysfunction 51
4-amino-5-vinyl-3(2H)-pyridazinones and related compounds: synthesis and evaluation of antinociceptive activity 51
Synthesis, biological evaluation, molecular modeling, and structural analysis of new pyrazole and pyrazolone derivatives as N-formyl peptide receptors agonists 48
'Proximity frequencies' a new parameter to evaluate the profile of GABAAR modulators 47
SYNTHESIS AND EVALUATION OF SOME PYRAZOLO[3,4-D]PYRIDAZINONES AND ANALOGUES AS PDE5 INHIBITORS POTENTIALLY USEFUL AS PERIPHERAL VASODILATOR 46
Novel formyl peptide receptor (FPR) agonists with pyridinone and pyrimidindione scaffolds that are potentially useful for the treatment of rheumatoid arthritis 46
Preparation of pyridazin-3(2H)-ones and their use as PDE4 inhibitors 45
Novel Sulfonamide Analogs of Sivelestat as Potent Human Neutrophil Elastase Inhibitors 45
Synthesis and evaluation of novel pyrrolo[2,3-d] and thieno[2,3-d]pyridazinones as in vitro antiproliferative agents 44
preparation of pyridazin-3(2H)-ones as phosphodiesterase 4 (PDE4) inhibitors 42
Preparation of pyridazin-3(2H)-ones as phosphodiesterase 4 (PDE4) inhibitors 41
Molecular manipulation of the 1,5,6,7-tetrahydro-4 H -indazol-4-one scaffold to obtain new human neutrophil elastase (HNE) inhibitors 41
NEW SYNTHESIS OF DIFFERENTLY FUSED PYRIDAZINONQUINOLINES 40
Alpha-2-agonist as analgesic agents 33
Pyridazin-3(2H)-one derivatives as novel PDE IV inhibitors 26
Synthesis and inverse virtual screening of new bi-cyclic structures towards cancer-relevant cellular targets 23
Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis 21
GABAA receptor modulators with a pyrazolo[1,5-a]quinazoline core: synthesis, molecular modelling studies and electrophysiological assay 18
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2H)-one as Novel Scaffold for FABP4 Inhibition 14
New quinoline-based PDE4 inhibitors through GSK-256066 fragment-based elaboration 14
4,5-Dihydro-5-Oxo-Pyrazolo[1,5-a]Thieno[2,3-c]Pyrimidine: A Novel Scaffold Containing Thiophene Ring. Chemical Reactivity and In Silico Studies to Predict the Profile to GABAA Receptor Subtype 13
Protective and Pain-Killer Effects of AMC3, a Novel N-Formyl Peptide Receptors (FPRs) Modulator, in Experimental Models of Rheumatoid Arthritis 11
Optimization of 4-amino-pyridazin-3(2H)-one as a valid core scaffold for FABP4 inhibitors 11
Ebselen analogues with dual human neutrophil elastase (HNE) inhibitory and antiradical activity 3
Totale 6.320
Categoria #
all - tutte 17.802
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.802


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.352 131 130 42 105 162 147 126 170 116 86 108 29
2020/20211.088 91 89 34 117 59 123 70 82 126 178 46 73
2021/2022508 16 34 40 17 17 32 17 36 20 39 121 119
2022/20231.232 123 271 47 102 99 207 153 65 99 5 42 19
2023/2024405 12 48 81 22 22 54 12 96 8 27 16 7
2024/202532 32 0 0 0 0 0 0 0 0 0 0 0
Totale 6.320